References
- Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, . Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710–18.
- Bettencourt PM. Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives. Heart 2005;91:1489–94.
- Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, . Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115–40.
- Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005;11:S15–20.
- Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC, Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976–82.
- Fagerberg B. [National and international guidelines ignore significant cause of heart failure. Diastolic dysfunction is often the cause of heart failure in the elderly and in women]. Lakartidningen 1998;95:5305–8.
- Rutten FH, Grobbee DE, Hoes AW. Diagnosis and management of heart failure: A questionnaire among general practitioners and cardiologists. Eur J Heart Fail 2003;5:345–8.
- Schaufelberger M, Bergh CH, Caidahl K, Eggertsen R, Furenas E, Lindstedt G, . Can brain natriuretic peptide (BNP) be used as a screening tool in general practice? Scand J Prim Health Care 2004;22:187–90.
- Olofsson M, Edebro D, Boman K. Are elderly patients with suspected HF misdiagnosed? A primary health care center study. Cardiology 2006;107:226–32.
- Cardiology TESo. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741–51.
- Bergstrom A, Andersson B, Edner M, Nylander E, Persson H, Dahlstrom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 2004;6:453–61.
- Roche. Roche Diagnostic Corporations 11/12/02 51 O(k) Summary K022516-Elecsys ProBNP NOV 1 9 2002 Introduction. 2002.
- FDA. Available at: http://www.fda.gov/cdrh/pdf2/k022516. (18 December 2002).
- Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, . The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 2006;56:327–33.
- Zaphiriou A, Robb S, Murray-Thomas T, Mendez G, Fox K, McDonagh T, . The diagnostic accuracy of plasma BNP and NT-proBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study. Eur J Heart Fail 2005;7:537–41.
- Hess G. N-Terminal pro-brain Natriuretic Peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Clin Lab 2005;51:167–72.
- Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, . Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254–8.
- Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388–442.